Abstract:Background: Recent studies have reported that an elevated intracellular glutathione (GSH) level is associated with resistance of non-small cell lung cancer (NSCLC) cell lines to cisplatin (CDDP). It is well-known that GSH is widely used in the clinic as a hepatoprotective agent. However, whether exogenous GSH can affect the sensitivity of NSCLC cells to CDDP remains unclear. The aim of this study is to evaluate the role of exogenous GSH in the resistance of A549 cells to CDDP. Methods: The effect of GSH and CDDP on the proliferation of A549 cells was analyzed by MTT assay. Subsequent experiments were conducted in A549 cells divided into four groups: control group (untreated cells), GSH group (treated with 120 mu g/ml GSH for 48 N. CDDP group (treated with 10 mu G/ml CDDP for 48 h) and CDDP+GSH group (treated with 10 mu g/ml CDDP+120 mu g/ml GSH for 48 M. Apoptosis was detected by flow cytometry. Light microscopy, fluorescence microscopy and electron microscopy were performed to study morphologic and ultrastructural differences among the four groups of cells. Intracellular GSH level and gamma-GCS expression were determined by immunohistochemistry (IHC). Cellular platinum uptake was assessed by inductively coupled plasma mass spectrometry (ICP-MS). Quantitative RT-PCR analysis was performed to measure the expression of caspase3, caspase9, bax, bc1-2 and MDR-1. Western blot analysis was conducted to examine the protein levels of GST-n, MRP-1 and P-gp. Results: Growth inhibition and apoptosis were reduced in A549 cells in the CDDP+GSH group compared to those in the CDDP group 48 h post-treatment. Alterations in cellular morphology and ultrastructure, as well as typical characteristics of apoptosis, were observed. Intracellular GSH and gamma-GCS levels were elevated by exogenous administration of GSH; in contrast, cellular platinum concentration fell rapidly. Relative to the CDDP group, the CDDP+GSH group exhibited 47.92%, 47.82% and 63.75% downregulation in caspase3, caspase9 and bax mRNA expression, respectively, and a 2.17-fold increase in bc1-2 mRNA level. In addition, there were 1.58-fold and 2.67-fold increases in the level of GST-n and MRP-1, respectively; however, the changes in MDR-1 and P-gp levels were not statistically significant. Conclusions: Our data demonstrated that exogenous GSH used as hepatinica in the clinic could induce resistance of A549 cells to CDDP by inhibiting apoptosis, elevating cellular GSH levels, inactivating the mitochondria-mediated signaling pathway, and increasingthe expression of GST-n, y-GCS and MRP1 to increase CDDP efflux.

Establishment of a Multidrug-resistance Cell Lines A549/CDDP from Human Lung Adenocarecinoma Cells

Effect of Lung Resistance-Related Protein on the Resistance to Cisplatin in Human Ovarian Cancer Cell Lines.

Establishment of a 5-DFUR-resistant human hepatocellular carcinoma cell model and preliminary study of the mechanisms of the drug resistance]

Establishment of a cisplatin-induced human esophageal carcinoma drug-resistant cell line and its biological characteristics

Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line

Ddifferent expression of multidrug-resistance and apoptosis related genes in human lung adenocarcinoma parental cell line A549 and cisplatin-resistant cell line A549DDP

Establishment and biological characteristics of Taxol-induced drug resistant human lung adenocarcinoma cell line

DEVELOPMENT OF A K562 MULTIDRUG-RESISTANT CELL LINE AND STUDY ON PROTEINS WITH ALTERED EXPRESSION

Reversal Effect of Ginsenoside Rg3 on Cisplatin-Resistant Human Lung Adenocarcinoma Cell Line(a549ddp) and Its Mechanisms

Establishment and Characterization of a Docetaxel-Resistant Variant of Human Lung Adenocarcinoma Cell Line SPC-A1

Establishment of Cisplatin-Resistant Human Endometrial Cancer Cell Line and the Study of Its Resistant Mechanisms

Establishment and Characterization of a Docetaxel-Resistant Human Prostate Cancer Cell Line.

Two 4N Cell-Cycle Arrests Contribute to Cisplatin-Resistance.

Identification of Drug Resistant Related Cdna in Lung Adenocarcinoma Cell Lines

[Establishment of Human Lung Adenocarcinoma Radioresistant Cell Lines and the Mechanism of Radioresistance].

Radiosensitivity of a Monoclonal Human Lung Adenocarcinoma Cell Line with MDR Phenotype Induced by CDDP: an in Vitro Study

Establishment of a docetaxel-induced human breast carcinoma drug-resistant cell line BT549/docetaxel and the mRNA expression of adenosine triphosphate binding cassette transporter G2, adenosine triphosphate binding cassette subfamily B member 1, multidrug

In Vitro Study of the Effect of Cyclosporine A, Tetrandrine and Their Combination on the Reversion of Multidrug Resistance in Leukemia Cell Line.

Exogenous Glutathione Contributes to Cisplatin Resistance in Lung Cancer A549 Cells.

[Cloning of Drug Resistance-Related Gene Fragments Differentially Expressed on Lung Adenocarcinoma Cell Line A549 and Its DDP-resistant Counterpart A549DDP].

Development and Characterization of a Gemcitabine-resistant Variant of Human Lung Adenocarcinoma Cell Line A549